1984 Volume 32 Issue Supplement4 Pages 184-187
A clinical administration of sulbactam/cefoperazone was conducted with eleven patients who were suffering from various infections. Sulbactam/cefoperazone was used intravenously one gram twice a day in ten patients and 2 grams twice a day in one. The results of the administration were as follows:
1. In eight patients of respiratory tract infection (four patients with pneumonia, two with chronic bronchitis, one with acute bronchitis and one with pyothorax) clinical effects of sulbactam/cefoperazone were all good except two cases (one case with pneumonia and one with acute bronchitis) with Mycoplasma infection.
2. In two cases with biliary tract infection, the therepeutic effects of sulbactam/cefoperazone were excellent in one, and good in one.
3. Sulbactam/cefoperazone obtained good effect in one patient with cystitis caused by Citrobacter.
4. No side effect was found, but elevation of titer of GOT, GPT were observed in two cases.